Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (Clin Infect Dis)

Journal PubWeight™ 20479.74‹?›

Top papers

Rank Title Year PubWeight™‹?›
1 Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. 2007 24.91
2 Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. 2009 22.98
3 Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. 2004 20.99
4 Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. 2008 20.88
5 Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. 1999 19.52
6 Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. 2009 18.19
7 The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. 2011 16.88
8 Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. 2008 16.51
9 Ongoing revolution in bacteriology: routine identification of bacteria by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. 2009 16.51
10 Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. 1998 16.20
11 Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. 2000 15.05
12 Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. 2006 14.63
13 Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Testing of the National Committee for Clinical Laboratory Standards. 1997 14.49
14 Epidemiology and outcome of zygomycosis: a review of 929 reported cases. 2005 13.97
15 The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. 2006 13.01
16 Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. 2001 12.73
17 Laboratory medicine in Africa: a barrier to effective health care. 2005 12.59
18 International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. 2011 12.29
19 Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america. 2010 11.65
20 Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. 2011 11.49
21 Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. 2002 11.30
22 Antimicrobial resistance in Streptococcus pneumoniae: an overview. 1992 11.24
23 Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. 2009 11.12
24 Using internet searches for influenza surveillance. 2008 11.11
25 Retention in care: a challenge to survival with HIV infection. 2007 10.66
26 Nosocomial bloodstream infections in United States hospitals: a three-year analysis. 1999 10.30
27 Plasmodium knowlesi malaria in humans is widely distributed and potentially life threatening. 2008 9.87
28 Invasive aspergillosis. 1998 9.72
29 Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999. 2001 9.59
30 The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America. 2008 9.57
31 The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. 1997 9.39
32 Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america. 2011 9.37
33 Determinants of mortality and nondeath losses from an antiretroviral treatment service in South Africa: implications for program evaluation. 2006 9.25
34 Practice guidelines for the diagnosis and management of skin and soft-tissue infections. 2005 9.23
35 Efficacy of antiretroviral therapy programs in resource-poor settings: a meta-analysis of the published literature. 2005 9.23
36 Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 beta-lactamases in New York City. 2004 9.21
37 Overview of nosocomial infections caused by gram-negative bacilli. 2005 9.06
38 Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. 2005 8.77
39 A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. 2007 8.65
40 Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia. 2008 8.58
41 Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. 2012 8.56
42 The global burden of nontyphoidal Salmonella gastroenteritis. 2010 8.19
43 Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study. 2012 7.97
44 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. 2002 7.81
45 Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America. 2000 7.80
46 Practice guidelines for the management of bacterial meningitis. 2004 7.79
47 Toxoplasmic encephalitis in AIDS. 1992 7.64
48 Molecular epidemiology: application of contemporary techniques to the typing of microorganisms. 1993 7.60
49 Primary liver abscess due to Klebsiella pneumoniae in Taiwan. 1998 7.51
50 Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression. 2006 7.42
Next 50